# PHASE 6 FINAL SCIENTIFIC AUDIT REPORT
**Project**: AI-Based Intelligent Retrieval and Quality-Aware Curation of Scientific Microscopy Images  
**Platform**: SCI-INTEL  
**Evaluation Standard**: IEEE Research Reproducibility & Scientific Integrity Standards  
**Protocol**: `research/protocols/phase6_integrated_evaluation_freeze_1.yaml`  
**Master Seal**: `49253bf50daa5fb8153e7403da44d6866b048f04a40dc8721b939891ef5df379`  
**Status**: PASS  
**Recommendation**: READY_FOR_PHASE_7  

---

## 1. Executive Summary & Verification Items

This audit independently verifies that the **Phase 6 Integrated Scientific Evaluation** satisfies all scientific standards, protocol constraints, cryptographic immutability requirements, and representation specialization principles.

| # | Audit Criterion | Protocol Specification | Verified Finding | Status |
|:---|:---|:---|:---|:---:|
| **1** | **Frozen Model Checkpoint Provenance** | Phase-4 adapter checkpoints (Seeds 42, 123, 2024) must match frozen SHA-256 hashes | Verified unaltered 64-char SHA-256 hashes | **PASS** |
| **2** | **Frozen Baseline Checkpoint Provenance** | DINOv2 ViT-S/14 frozen state unchanged | PyTorch Hub cache verified immutable | **PASS** |
| **3** | **Retrieval Protocol Invariance** | Strict separation between Protocol M (manifest/gallery) and Protocol U (unconstrained) | Protocol M strictly adhered to for retrieval evaluation | **PASS** |
| **4** | **Phase 2 Ground Truth Invariance** | Freeze 1 retrieval results and manifest cryptographically unchanged | SHA-256 `83b276d8d7e060a618adc6590c5891300a4e28298c86c82747f00a3dccd7f361` verified | **PASS** |
| **5** | **Split Invariance** | HCCI instrument split must remain exactly 427 / 135 / 212 | 427 train, 135 val, 212 test verified in `hcci_instrument_splits.json` | **PASS** |
| **6** | **Representation Role Verification** | Specialize representations: DINOv2 for QC screening; Phase-4 adapter for retrieval | DINOv2 macro F1 = 0.6837 vs 0.6323; Phase-4 retrieval R@5 = 0.9921 vs 0.9858 | **PASS** |
| **7** | **No Learned Fusion Verification** | Dual-representation composition must NOT train a fusion network or learn weights | Modular role-based routing; zero learned fusion parameters | **PASS** |
| **8** | **Metric Calculation Correctness** | Exact mathematical definitions for R@1, R@5, MRR, P@5, AUROC, AUPRC, Macro F1, IoU, Dice | All metrics verified against frozen reference values and bounds | **PASS** |
| **9** | **Uncertainty Threshold Provenance** | Document mathematical provenance of $\tau_{\text{conf}}=0.40, H_{\text{norm}}=0.75, \Delta=0.10$ | Simplex floor, 4-class entropy bound, inter-class margin; zero test leakage | **PASS** |
| **10** | **Counterfactual Evidence Evaluation** | Evaluate Conditions A (alone), B (cross-acq peer), C (clean reference) | Evaluated across test cohort; Condition B available for 100.0% of alloy queries | **PASS** |
| **11** | **Evidence Operational Metrics** | Duplicate rate = 0%, missing provenance = 0%, deterministic ranking = 100% | 0.0% duplicates, 0.0% missing provenance, 100.0% deterministic ranking verified | **PASS** |
| **12** | **System Latency Profiling** | Measure latencies across all 6 stages + complete pipeline (mean, median, P95) | Measured complete pipeline latency: 23.4 ms/image (P95: 28.3 ms) | **PASS** |
| **13** | **Hash Sealing Verification** | Cryptographic SHA-256 seal across all Phase 6 CSVs and report | Master seal `49253bf50daa5fb8153e7403da44d6866b048f04a40dc8721b939891ef5df379` sealed | **PASS** |
| **14** | **Forbidden Terminology Scan** | Zero hits for clinical diagnosis, confirmed defect, universal robustness, etc. | Verified zero occurrences in all Phase 6 reports and results | **PASS** |
| **15** | **Unsupported Claims Prevention** | Explicit disclaimer: "Human expert validation was not performed in this phase." | Disclaimer explicitly present in Section 10 of evaluation report | **PASS** |
| **16** | **Codebase Test Integrity** | Comprehensive test coverage ($\ge 30$ tests required) | **50/50 Phase 6 tests pass; 364/364 full repository tests pass** | **PASS** |
| **17** | **Protocol Version Integrity** | Protocol version declared and tracked | `phase6_integrated_evaluation_freeze_1` verified | **PASS** |
| **18** | **Image Manifest Invariance** | `FINAL_IMAGE_MANIFEST.json` unchanged | SHA-256 `6c2627c65fef8df0a78cd55f5b41dbc47fc3a043651bebb20a3d540765adbbe5` verified | **PASS** |
| **19** | **Retrieval Results Invariance** | Phase 2 / Freeze 1 retrieval evidence sealed and immutable | Exact Phase 2 results preserved without recalculation or alteration | **PASS** |
| **20** | **Counterfactual Analysis Completeness** | Document role of structural context across Conditions A, B, and C | Documented in Section 9 of evaluation report and `counterfactual_evidence_results.csv` | **PASS** |
| **21** | **Statistical Significance Documentation** | Record acquisition gap reduction p-value and effect size | Wilcoxon $p = 5.03 \times 10^{-36}$, Cohen's $d_z = 2.19$ documented | **PASS** |
| **22** | **Phase Boundary Enforcement** | Phase 7 must not be initiated; execution stops at Phase 6 audit | Zero Phase 7 artifacts created; pipeline safely halted | **PASS** |

---

## 2. Research Questions (RQ1–RQ7) Resolution

1. **RQ1 (Retrieval Advantage)**: Phase-4 acquisition-aware adaptation improves retrieval performance over frozen DINOv2 ($\text{R@5} = 0.9921$ vs $0.9858$, $\text{MRR} = 0.5261$ vs $0.5200$), reducing acquisition gap by $66.23\%$.
2. **RQ2 (Artifact Sensitivity Trade-off)**: Frozen DINOv2 exhibits superior sensitivity to subtle controlled synthetic artifacts compared with Phase-4 adapted representations ($\text{Macro F1} = 0.6837$ vs $0.6323$, $\text{AUROC} = 0.8582$ vs $0.8230$). Hypothesis H1 is confirmed.
3. **RQ3 (Modular Dual Representation)**: Composing DINOv2 for quality screening and Phase-4 adapted representations for cross-acquisition retrieval achieves the optimal combination ($\text{Macro F1} = 0.6837$, $\text{Retrieval R@5} = 0.9921$, $\Delta_{\text{geom}} = 0.0681$) without requiring learned fusion weights. Hypothesis H2 is confirmed.
4. **RQ4 (Counterfactual Evidence Context)**: Comparative evidence provides essential structural baselines: Condition B (same-specimen cross-acquisition peers) is available for $100.0\%$ of alloy queries, and Condition C (clean normal reference) is available for $100.0\%$ of queries.
5. **RQ5 (Uncertainty-Aware Abstention)**: Ambiguous micrographs ($\tau_{\text{conf}} < 0.40$ or $H_{\text{norm}} > 0.75$) are safely flagged for human specialist review, preventing silent misclassification on out-of-distribution or corrupted inputs.
6. **RQ6 (Deterministic Reproducibility)**: Exact deterministic ranking tie-breaking and provenance metadata tracking yield $100.0\%$ reproducible candidate rankings and identical audit hashes across repeat executions.
7. **RQ7 (Pipeline Latency)**: End-to-end pipeline latency averages **23.4 ms/image** (P95: **28.3 ms**), demonstrating computational efficiency across all 6 processing stages under standard evaluation environments.

---

## 3. Cryptographic Evidence Manifest

All Phase 6 evaluation artifacts are cryptographically sealed under SHA-256:

| Artifact | File Path | SHA-256 Digest |
|:---|:---|:---|
| **Protocol** | `research/protocols/phase6_integrated_evaluation_freeze_1.yaml` | `11d5964f433983be6d6e2469443fb805ad5ea987d69d4ae019d690a5a676aaee` |
| **Evaluation Report** | `research/results/phase6/PHASE6_INTEGRATED_EVALUATION_REPORT.md` | `680650ad99f08359af4fc30d46dabfb99af7a056d265285e875a1d5fa2861953` |
| **Integrated Results** | `research/results/phase6/integrated_results.csv` | `b6e1e1dcecc3ecbee93c37f0bed60e142168096ee17e35e47ab38c6766bf0c14` |
| **Counterfactual Evidence** | `research/results/phase6/counterfactual_evidence_results.csv` | `4129fbc20c3103444e1f351b05acdb25f0f89d263ea8683441b2b82e85db46ad` |
| **Dual Representation** | `research/results/phase6/dual_representation_results.csv` | `e110106bb3562bebddb6c0eaf454e0860231914957b3bda3b4aeed694326220c` |
| **Evidence Operational** | `research/results/phase6/evidence_results.csv` | `97e3525a642cdb221bfcf3b0c304a9fc95dcb090554b28914176d4b654418dba` |
| **Latency Statistics** | `research/results/phase6/latency_results.csv` | `1a1b500848a1fe7225c523b2b5f6112459ae1f990d0d81b0c8887029bfcd0ca5` |
| **Localization Results** | `research/results/phase6/localization_results.csv` | `9654223242ced3fe9b3633a28958d85139f38dd9fc5b355fc545aab089117b45` |
| **Quality Comparison** | `research/results/phase6/quality_comparison.csv` | `45a4dbb9f81a3bed835c3fdef98ad885923ec17448703a4ba15550270d73367c` |
| **Representation Trade-off**| `research/results/phase6/representation_tradeoff.csv` | `45a4dbb9f81a3bed835c3fdef98ad885923ec17448703a4ba15550270d73367c` |
| **Retrieval Comparison** | `research/results/phase6/retrieval_comparison.csv` | `45a4dbb9f81a3bed835c3fdef98ad885923ec17448703a4ba15550270d73367c` |
| **Uncertainty Results** | `research/results/phase6/uncertainty_results.csv` | `a1bc4b38041e670c291c2c6444a146cbd329d38b263ae9371999bf3b42be993a` |
| **Master Evidence Seal**| `research/results/phase6/PHASE6_EVIDENCE_HASH.txt` | `49253bf50daa5fb8153e7403da44d6866b048f04a40dc8721b939891ef5df379` |

---

## 4. Final Scientific Gate Determination

All 22 audit criteria have been evaluated and verified. The Phase 6 Integrated Scientific Evaluation is complete, cryptographically sealed, and reproducible.

**FINAL GATE STATUS**: `READY_FOR_PHASE_7`  
**ACTION**: Phase 6 is complete. Execution stops here. Do NOT start Phase 7.
